
forecasting the performance of cinema
sites operated by the Group, inmultiple
countries, this results in an element
ofjudgement being applied to the
valuation of an individual cash
generating unit (“CGU”), predominantly
at cinema site level. At each Balance
Sheet date, Management prepares an
assessment which estimates the value
inuse of the CGUs to which the
tangiblefixed assets are allocated.
Where individual sites’ cash flows are
notconsidered independent from one
another, mainly due to strategic or
managerial decisions being made
acrossmore than one site, they may
becombined into a single CGU.
The resulting calculation is sensitive to
the assumptions in respect of future
cash flows and the discount rate applied.
Following impairment charges caused
by the pandemic, affected by the level of
right of use assets held at CGUs where
no lease amendment had been applied
since the outbreak of the pandemic,
there is also a risk that CGUs are valued
below the recoverable amount and
reversal of impairment is required.
The main assumptions over growth rates,
the impact of one-off events, expected
cost increases and discountrates are
updated to reflectManagement’s best
estimate. The impact of COVID-19, its
impact on the Group’s forecast revenue
and the Group’s credit rating resulted in
material one off reductions invalue in
CGUs in each territory. There has been no
material change to forecasts or discount
rates applied for CGU impairment testing
since the 2021 assessment.
When considering the appropriateness
of the discount rate, Management
assess the territory specific discount
rates, and ensure that they are updated
for current market information and
theGroup’s current leverage. The
assessment for the current year
included consideration of the
deterioration in the Group’s credit
ratingand changes to its cost of debt
due to new issuances in the year.
At the year-end Management
preparedtheir valuation models for the
Committee’s consideration, together
with their proposed site impairments,
and drew the Committee’s attention to
any specific judgements taken within
the models. Management confirmed to
the Committee that they have applied a
consistent Group-wide methodology in
the preparation of the valuation models.
This included applying reduction in
forecast cash flows at a CGU level,
implied by the weighted scenario
forecast analysis carried out for the
Group’s Going Concern assessment.
In considering potential reversals of
impairment, Management confirmed
that they had only recognised a reversal
when driven by changes to the right of
use asset held at a CGU, caused by a
lease amendment signed during the
period. All other model parameters for
reversals of impairment were consistent
with those applied in assessing
impairment charges at December 2020.
The committee reviewed the
methodology and assumption
appliedby Management in reaching
their impairment assessments. A key
assumptions addressed were the
forecast return to pre pandemic levels
oftrading, which were assessed for
consistency with the Groups
wider forecast recovery.
The Committee satisfied itself that
theapproach was appropriate, the
assumptions reasonable and the
impairments proposed were complete
and accurate. The Committee also
satisfied itself through enquiry of
Management and review of the Board
papers that all significant events which
may have impacted on the valuation of
PPE and right of use assets had been
appropriately captured in Management’s
assumptions and reflected in the
valuation models and that appropriate
disclosures, including in relation to
sensitivities, had been included in the
financial statements.
Valuation of investments
As detailed in Note 13 to the financial
statements, the continued impact of
COVID-19 resulted in an increased risk to
the valuation of the Groups investment
in National Cinemedia LLC (NCM).
This risk was driven by changes to the
forecast profitability of NCM, reductions
in its forecast distributions and a
material reduction in its share price.
The forecast cash flows arising from the
investment in the form of distributions
require judgement and result in
sensitivity in thevaluation of NCM.
Management’s value in use assessment
was based on forecast cash flows, which
were applied through using NCM own
forecast cash flows and use of
theweighted scenario forecasts
consideredin the Group’s Going
Concern assessment. A WACC was
derived using relevant external market
data and considering the Group’s
creditworthiness at the date ofthe
assessment. Management’s fair value
less cost to sell assessment was
determined by reference to the
tradedshare price in NCM Inc (as set
outin note 13) at 31 December2021.
The Committee has considered
information supplied by Management
and satisfied itself that theapproach
and methodology applied by
Management was appropriate.
Accounting for new financing
arrangements
During the year the Group entered new
financing agreements. The nature and
complexity of certain features of these
arrangements are such that their
treatment and valuation represent
agreater risk than other agreements
theGroup has historically been party
to.These agreements included the
issueof a convertible bond with
certainembedded derivative financial
instruments. Each component of the
new arrangement, their contractual
terms and interaction with other
contracts in place and the appropriate
treatment under IFRS 9: Financial
Instruments were considered by
Management. Detailed disclosures
inrespect of these treatments and
valuations and their impact on the
financial statements are set out in
note 26.
Having considered documentation and
analysis presented to it, the Committee
satisfied itself that Management
obtained appropriate professional
advice in addressing these contractual
arrangements and correctly recognised
them in the financial statements.
IFRS 16: Leases
As detailed in note 20, on adoption of
IFRS 16 “Leases” leases are recognised
as a right-of-use asset and a
corresponding liability at thedate at
which the leased asset is available for
use by the Group in the Consolidated
Statement of Financial Position.
Each lease payment is allocated
between the liability and finance cost.
The finance cost is charged to the
Consolidated Statement of Profit or
Loss over the lease period so as to
produce a constant periodic rate of
interest on the remaining balance of the
liability for each period. Both principal
and finance cost elements of lease
payments are recognised within
financing cash flows within the
Consolidated Statement of Cash Flows.
AUDIT COMMITTEE REPORT CONTINUED
Cineworld Group plc
Annual Report and Accounts 2021
58